AlcoChange
Research type
Research Study
Full title
AlcoChange: An Open Label Pilot Study of Smartphone Monitoring for Alcoholic Liver Disease
IRAS ID
190682
Contact name
Kevin Moore
Contact email
Sponsor organisation
University College London
Duration of Study in the UK
1 years, 0 months, 1 days
Research summary
[TO BE UPDATED AS PART OF RESP PO]
The primary objective is to determine the effect of use of the AlcoChange in vitro diagnostic device on self-reported alcohol use at 3 months, amongst patients with ALD. The hypothesis is that use of the AlcoChange device will lead to a >20% reduction in self-reported alcohol use at 3 months.
REC name
London - Bromley Research Ethics Committee
REC reference
16/LO/0290
Date of REC Opinion
30 Mar 2016
REC opinion
Further Information Favourable Opinion